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INTRODUCTION: Personality traits have been associated with primary depression. However, it is not known whether
this association takes place in the case of depression comorbid with fibromyalgia.
OBJECTIVE: The authors investigated the association between a current major depressive episode and temperament
traits (e.g., harm avoidance).
METHOD: A sample of 69 adult female patients with fibromyalgia was assessed with the Temperament and
Character Inventory. Psychiatric diagnoses were assessed with the Mini-International Neuropsychiatric Interview
severity of depressive symptomatology with the Beck Depression Inventory, and anxiety symptomatology with the
IDATE-state and pain intensity with a visual analog scale.
RESULTS: A current major depressive episode was diagnosed in 28 (40.5%) of the patients. They presented higher
levels of harm avoidance and lower levels of cooperativeness and self-directedness compared with non-depressed
patients, which is consistent with the Temperament and Character Inventory profile of subjects with primary
depression. However, in contrast to previous results in primary depression, no association between a major
depressive episode and self-transcendence was found.
CONCLUSIONS: The results highlight specific features of depression in fibromyalgia subjects and may prove
important for enhancing the diagnosis and prognosis of depression in fibromyalgia patients.
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INTRODUCTION
Fibromyalgia (FMS) is a syndrome characterized by
chronic widespread musculoskeletal pain and stiffness in
association with fatigue and poor sleep. The classification of
the American College of Rheumatology Criteria for FMS1
includes the presence of pain in all four body quadrants in
combination with excess tenderness to manual palpation in
at least 11 of 18 muscle–tendon sites, in the absence of
clinically demonstrable peripheral nociceptive causes.
Although some biological mechanisms have been identified,
the etiology and pathogenesis of FMS remain unclear.2,3 The
prevalence of FMS in the general population is estimated to
be between 1.3% and 4.8%.4 Patients with FMS also
frequently suffer from emotional distress and/or psychiatric
disorders.5,6
Depression in a medical setting or comorbid with medical
conditions has been reported to be frequent, difficult for
general practitioners to recognize ,7–9 associated with
increased morbidity and to have different psychopatholo-
gical presentation.10 Of note, the prevalence of depression is
increased in fibromyalgia patients compared with medically
healthy individuals.11,12 Among patients with fibromyalgia,
the current and 12-month prevalence of major depression
(MDD) has been reported to be between 20% and 30%13,14 in
various studies, but also from 30% to 80% in others,15
compared with 4% to 6%, respectively, for current and 12-
month prevalence of MDD in the general population.16,17
The prevalence of MDD appears to be higher in FMS
patients than in rheumatoid arthritis patients, according to
some18,19 but not all20 reports. An epidemiological study
placed fibromyalgia as the second most common general
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medical condition associated with MDD, with an odds ratio
(OR) of 3.4.21 In addition to this increased prevalence,
depression in FMS has been reported to be associated with
sexual dysfunction,22 lower rates of physical therapy23 and
vitamin D deficiency.24 Considering the relevance of the
association between personality and MDD in the general
population, it is pertinent to investigate whether this
association extends to patients with fibromyalgia or not.
Studying the association between a specific personality trait
(harm avoidance) and the depression comorbid with FMS
may bring inputs about the nature of such depression and
its potential response to treatment.
Several studies have reported a specific pattern of
personality traits in MDD subjects (primary depression),
as assessed using Cloninger’s Temperament and Character
Inventory (TCI).25 The TCI is based on a psychobiological
model of personality and evaluates 7 traits referring to
temperament and character. Temperament evaluation
includes 4 dimensions: novelty seeking (NS), harm avoid-
ance (HA), reward dependence (RD) and persistence (P).
The assessment of the character includes the evaluation of
self-transcendence (ST), self-directedness (SD) and coopera-
tiveness (C). Prior studies have consistently reported that
MDD was associated with higher HA, but not NS and RD
dimensions.26,27 HA scores appear to be directly correlated
with the severity of depressive symptomatology. In addi-
tion, other studies investigating the character personality
traits (ST, SD and C) have suggested that MDD subjects tend
to have higher scores of HA and ST and lower scores of SD
and C compared with healthy volunteers.28–30
Altered personality traits have also been described in
chronic pain patients by some but not all authors.31 A
pattern close to that described in MDD (i.e., increased HA
scores and decreased SD scores) has been reported in
patients with non-specific musculoskeletal disorders,32
tension-type headache33 and migraine.33,34 Moreover, a
correlation of HA, SD and C with depression severity has
been reported in tension-type headache patients,33 and
some authors have suggested that the association of chronic
pain with TCI dimensions is caused, at least in part, by the
presence of comorbid depression.34 Two studies have
previously reported35,36 an association between higher HA
and higher Beck Depression Inventory scores in neurologi-
cal and cardiac patients. The association between depres-
sion and HA has physiological and clinical implications.
Physiologically, HA has been associated with serotonergic
dysfunction37 and, clinically, HA independent of the other
dimensions has been related to an increased risk of
developing depression38,39 and to the response to antide-
pressant treatment.27
Three studies40–42 have previously investigated the
association between depression and personality aspects in
FMS patients. Johnson et al. (1997)40 evaluated the self-
esteem structure in 61 female FMS patients; they found that
depressed FMS patients present a self-esteem structure with
lower sense of self-esteem, lower self-assertiveness and less
emotional candor, different from the non-depressed FMS
patients. Nordahl and Stiles (2007)42 reported a sociotropic
personality style similar to MDD only in FMS patients with
current or lifetime history of MDD. In another study, Mazza
et al. (2008),41 using the Beck Depression Inventory and the
TCI, reported a depressive state and trait correlation with
HA and strong depressive state association with SD in FMS
patients. None of the above-mentioned studies used an
instrument that captures parameters similar to those
captured by the TCI; and, to our knowledge, no study has
specifically investigated the association of TCI personality
traits with a current major depressive episode (MDE) in
FMS patients. Thus, our main hypothesis was that a current
MDE in FMS patients is associated with harm avoidance
(HA); secondarily, we investigated the association of current
MDE with other TCI dimensions.
MATERIALS AND METHODS
Patients
Patients included in this study were recruited between
June 2006 and September 2008 from the Rheumatology and
Neurology departments of the Hospital das Clinicas da
Faculdade de Medicina da Universidade de Sao Paulo,
Brazil. The neurology unit specializes in chronic pain
patients, and the rheumatology unit specializes in the
diagnosis and treatment of FMS. Patients were referred to
a screening interview by their neurologist or rheumatolo-
gist. Physicians were instructed to refer all female patients
aged 18 years or older with FMS according to the American
College of Rheumatology Criteria.1 Only females were
included in the study because FMS is 10 times more
prevalent in women.
The exclusion criteria included major medical conditions,
debilitating neurological conditions, bipolar disorder, dys-
thymic disorder, psychosis and other DSM-IV Axis I
disorders, except anxiety and major depressive episode,
because of the high prevalence of these diagnoses. Patients
with inability to comprehend the instruments were also
excluded.
During the study period, 279 patients were referred to the
screening visit. Forty-nine patients refused to participate in
the study or missed the scheduled appointment. Fifty-nine
patients were excluded because of medical comorbidities, 29
due to psychiatric conditions and 73 because of inability to
comprehend the instrument instructions. Sixty-nine patients
were included in the study analysis.
Measures
Aquestionnairewas used to collect sociodemographic data
including age, marital status, educational level, employment
status and total family income. Recorded clinical character-
istics included length of history of FMS symptomatology
(years) and current psychopharmacological treatment (anti-
depressant, benzodiazepine, antipsychotic).
Psychiatric disorders were diagnosed by a psychologist
(D.M.S.) using the Brazilian version43 of the Mini-
International Neuropsychiatric Interview (M.I.N.I.).44 The
M.I.N.I. is a structured interview designed to access the
psychiatric diagnosis in accordance with the DSM-IV and
ICD-10 criteria.44
The Beck Depression Inventory (BDI)45 was used to assess
the severity of depression. BDI is a 21-item self-report
questionnaire that has been widely used to evaluate
medically ill depressed patients. The Brazilian version was
validated by Gorenstein et al. (1996).46
The IDATE-state,47 a 20-item self-report questionnaire,
was used to measure anxiety severity; we used the Brazilian
version validated by Gorenstein et al. (1996).46
Comorbid medical conditions were evaluated with the
Cumulative Illness Rating Scale (CIRS),48 a questionnaire that
measures the severity of all comorbid illnesses and groups
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them into 13 organ systems: cardiac, hypertension, vascular,
respiratory, EENT (eye, ear, nose, throat, larynx), upper
gastrointestinal (GI), lower GI, hepatic, renal, other GU,
musculoskeletal–integumentary, neurological, endocrine–
metabolic. The interviewer (D.M.S.) asked the patient about
the 13 organ systems and rated the severity of illnesses for
each organ as none, mild, moderate, severe or extremely
severe.
Pain severity was evaluated with a visual analog scale
(VAS). The scale anchors were ‘‘no pain’’ and ‘‘pain as bad
as it could be’’, and with a numeric range from 0 to 10
centimeters. Patients were questioned about pain intensity
in the previous week.
Personality traits were assessed using the self-administrated
Brazilian version of TCI49 consisting of 240 self-descriptive,
true/false items, assessing 4 temperament dimensions (NS,HA,
RD, P) and 3 character dimensions (SD, C, ST). NS includes 4
subdimensions: NS1, exploratory excitability versus stoic
rigidity; NS2, impulsiveness versus reflection; NS3, extrava-
gance versus reserve; NS4, disorderliness versus regimentation.
HA consists of 4 subdimensions: HA1, anticipatory worry and
pessimism versus uninhibited optimism; HA2, fear or uncer-
tainty versus confidence; HA3, shyness with stranger versus
gregariousness; HA4, fatigability versus vigor. The third
dimension of temperament, RD, includes 2 subdimensions:
RD1, sentimentality; and RD3, dependence versus indepen-
dence. P expresses the preservation of a form of behavior as
resistance to frustration. The first character dimension of SD has
a further 5 subdimensions: SD1, responsibility versus blame;
SD2, purposefulness versus lack of goal or direction; SD3,
resourcefulness; SD4, acceptance versus self-striving; and SD5,
congruent second nature. C includes 5 subdimensions: C1,
social acceptance versus social intolerance; C2, empathy versus
social disinterest; C3, helpfulness versus unhelpfulness; C4,
compassion versus revengefulness; and C5, integrated con-
science. ST includes 3 subdimensions: ST1, self-forgetfulness
versus self-conscious experience; ST2, transpersonal identifica-
tion versus self-isolation; ST3, spiritual acceptance versus
rational materialism.25,50
The research project was approved by the ethics
committee of the HC-FMUSP, and all patients gave written
informed consent.
Statistics
Comparisons between FMS patients with and without
current MDE were performed with t-tests (for normally
distributed variables), with Mann–Whitney U-tests (for
variables without normal distribution) and with chi-square
tests (for categorical variables). The TCI dimensions did not
show normality; consequently, we used the Mann–Whitney
U-test to investigate our main hypothesis (association of
current MDE with HA) and our secondary hypotheses
(association of current MDE with other TCI dimensions).
We used Spearman’s correlation tests to investigate correla-
tion between TCI dimensions and BDI and IDATE scores.
All tests were performed with an alpha of 0.05, two-tailed.
RESULTS
The 69 FMS patients included in this study had a mean
age of 46.3 (¡8.9) years, 9.8 (¡3.7) years of schooling, 65.2%
were married and 65.2% were Caucasian. The mean length
of FMS symptomatology was 8.9 (¡6.5) years, and the mean
pain intensity on the VAS was 7 (¡1.9). Sixty-six percent of
the patients were using antidepressants, 8.6% were using
benzodiazepine and 23.1% were using antipsychotics.
Current MDE was diagnosed in 28 (40.5%) and anxiety
disorder in 11 (15.9%) patients (Table 1).
We found no significant differences on sociodemographic
or clinical characteristics between FMS patients with or
without a diagnosis of MDE (Table 1).
Compared with non-depressed subjects, patients with
MDE had higher HA scores on the main HA scale (p= 0.002)
and on 3 out of 4 HA subscales: HA1 (p , 0.001), HA3
(p= 0.040) and HA4 (p= 0.023) (Table 2). Patients with MDE
exhibited lower SD (p= 0.001) and lower C (p= 0.027)
compared with non-depressed patients. There were no
significant differences on the other TCI scales (NS, P, RD
and ST) between depressed and non-depressed FMS
patients (Table 2).
Among MDE patients, the BDI was positively correlated
with HA (r= 0.384) and ST (r= 0.466) scores. A negative
correlation was found between SD and BDI (r= –0.646). The
IDATE-state was negatively correlated with the SD (r=
–0.397) and C (r= –0.446) scales, and positively correlated
with HA (r= 0.367). There was no significant association
between pain intensity and TCI traits.
DISCUSSION
In this study of 69 FMS patients, we found that current
MDE was associated with higher HA scores than in non-
depressed subjects, and that HA scores were positively
correlated with the severity of depressive symptoms
(measured by the BDI). In addition, in a post hoc analysis
(two-way ANOVA) using HA as the dependent variable
and including anxiety disorders as a potential confounder,
we found that MDE was associated with HA independently
of anxiety disorders. High HA scores indicate a tendency to
be cautious, pessimistic, insecure and fearful; these subjects
present shyness in most social situations, feel chronically
tired and fatigued.51 In addition, MDE patients had lower
SD and C scores than non-depressed FMS patients. Those
with low SD scores are characterized by difficulties in
accepting responsibility, lack of long-term goals, low self-
esteem and are often dependent, whereas individuals with
low C scores are characterized by social intolerance, social
disinterest and always seeking their own profit.51 These
results suggest that MDE in FMS patients resembles
primary depression described in non-medically ill psychia-
tric patients. However, besides the same three traits
described above in our depressed FMS patients, previous
studies with psychiatric patient samples have revealed that
patients with primary MDD also have increased ST scores
compared with healthy control subjects.28–30 In our sample,
ST scores were no different in depressed compared with
non-depressed FMS patients. It is possible that normal
levels of ST may be a characteristic of MDE associated with
FMS, in contrast to primary depression.
To our knowledge, two studies used the TCI in FMS
patients,41,52 and only one evaluated the association of TCI
with depressive symptoms.41 In that study, Mazza et al.
(2009) investigated the effect of selective serotonin reuptake
inhibitors (SSRI) on TCI dimensions over a period of 6
months in 60 FMS patients compared with 80 healthy
control subjects.41 They reported a significant decrease in
BDI scores with treatment and a depressive state and trait
dependence of HA and strong depressive state dependence
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of SD in FMS patients. Consistent with our results, Mazza
et al. (2009) also did not find an association between ST and
depression trait or state.
Regarding the investigation of other aspects of depression
comorbid with FMS, we found 3 studies that compared
depressed with non-depressed FMS patients. In their study,
Nordahl and Stiles (2007)42 compared 25 depressed with 19
non-depressed FMS patients and also with two other
groups, one with 43 psychiatric outpatients with MDD
and another with 41 healthy control subjects. They found
that the cognitive personality style that is typical of MDD
(higher levels of sociotropy and dysfunctional attitudes)
was only present in FMS patients if they met the criteria for
a concurrent or lifetime history of MDD. This is a finding in
line with ours, reinforcing the relevance of depression for
the dysfunctional aspects of FMS patients. Johnson et al.
(1997)40 investigated the self-esteem structure in 61 female
FMS patients compared with 40 healthy control subjects and
37 non-depressed patients with rheumatoid arthritis.
Depressed FMS patients presented a self-esteem structure
characterized by low basic self-esteem combined with a
demanding need to earn self-esteem, which is a distinct
pattern compared with non-depressed FMS patients, rheu-
matoid arthritis patients and healthy control subjects. The
authors proposed that depressed FMS patients represent a
specific group of FMS patients.40 Okifuji et al. (2000)23
reported that depressed FMS patients reported more
maladaptative thoughts and functional limitations than
non-depressed FMS patients.
Studies32–34 that have investigated the association of
chronic pain with TCI dimensions have reported that the
TCI differences from healthy control subjects could not be
explained totally by the pain condition and were explained,
at least in part, by a greater presence of depressive and
anxiety symptoms among FMS patients. In this particular,
IDATE-state scores were positively correlated with HA and
negatively correlated with SD and C. In addition, in the post
hoc analysis using HA as the dependent variable, including
MDE and anxiety disorders as independent variables, we
found that anxiety disorders were associated with HA
Table 1 - Sociodemographic and clinical characteristics of female FMS patients with and without a current major
depressive episode.
Sociodemographic and clinical
characteristics Total sample (N=69) MDE absent (N=41) MDE present (N=28) p value
Categorical variables* N (%) N (%) N (%)
Marital status (married) 45 (65.2) 27 (65.9) 18 (64.3) 0.788
Ethnicity (Caucasian) 45 (65.2) 28 (68.3) 17 (60.7) 0.623
Benzodiazepine (using) 6 (8.6) 3 (7.3) 3 (10.7) 0.623
Antidepressant (using) 46 (66.6) 27 (65.9) 19 (67.9) 0.862
Antipsychotic (using) 16 (23.1) 10 (24.4) 6 (21.4) 0.775
Musculoskeletal comorbidities
(presence)
42 (60.8) 25 (60.9%) 17 (60.7) 0.092
Anxiety disorders 11 (15.9) 6 (14.6) 5 (17.8) 0.748
Numerical variables{ Mean (SD) Mean (SD) Mean (SD)
Age 46.33 (¡8.9) 47.85 (¡8.6) 44.11 (¡9.1) 0.088
Total family income 1794.7(¡1311.8) 1843.66(¡1335) 1723.21(¡1297) 0.711
Educational level 9.85 (¡3.7) 9.88 (¡3.9) 9.82 (¡3.6) 0.952
Comorbidities (CIRS) 16.10 (¡3.4) 16.22 (¡3.7) 15.93 (¡2.8) 0.730
FMS history (years) 8.98 (¡6.5) 8.73 (¡0.9) 9.38 (¡1.5) 0.701
Pain intensity 7.04 (¡1.9) 6.87 (¡0.2) 7.28 (¡0.4) 0.129{
*Chi-square.
{t-test.
{Mann–Whitney.
CIRS =Cumulative Illness Rating Scale; MDE=major depressive episode.
Table 2 - Comparison between temperament and
character inventory dimensions of female FMS patients
with and without a current major depressive episode.
MDE absent
(N=41)
MDE present
(N=28) p value
Novelty seeking 16.63¡5.24 15.18¡4.73 0.364
NS1 6.00¡2.10 4.68¡2.50 0.032
NS2 3.51¡2.17 3.61¡1.77 0.785
NS3 4.66¡2.33 4.36¡2.31 0.639
NS4 2.46¡1.91 2.54¡1.75 0.813
Harm avoidance 18.37¡6.85 23.79¡6.90 0.001*
HA1 4.59¡2.62 7.25¡2.61 0.000
HA2 5.54¡1.38 5.71¡1.38 0.481
HA3 3.95¡2.31 5.11¡2.33 0.040
HA4 4.29¡2.51 5.71¡2.46 0.023
Reward
dependence
14.32¡3.62 13.39¡3.52 0.201
RD1 7.10¡1.73 7.43¡1.95 0.452
RD3 4.54¡2.32 3.18¡2.16 0.018
RD4 2.68¡1.39 2.79¡1.60 0.900
Persistence 5.34¡1.39 4.75¡1.94 0.167
Self-
directedness
31.34¡6.86 25.39¡7.21 0.001*
SD1 6.00¡1.43 4.29¡2.09 0.001
SD2 5.80¡1.66 4.29¡1.98 0.000
SD3 3.29¡1.50 2.25¡1.43 0.004
SD4 7.61¡1.86 6.82¡2.14 0.099
SD5 8.63¡2.33 7.75¡2.34 0.095
Cooperativeness 33.66¡5.17 31.57¡4.04 0.027*
C1 6.24¡1.91 6.00¡1.81 0.474
C2 5.00¡1.30 4.54¡1.17 0.186
C3 6.12¡1.12 5.75¡1.08 0.128
C4 9.07¡1.21 8.75¡1.27 0.229
C5 7.02¡1.44 6.57¡1.23 0.111
Self-
transcendence
18.46¡4.54 18.79¡7.07 0.717
ST1 6.29¡1.83 6.32¡2.68 0.629
ST2 4.73¡1.76 5.00¡2.14 0.577
ST3 7.46¡2.65 7.46¡3.61 0.644
The Mann–Whitney test was used to compare the temperament and
character inventory dimensions between FMS patients with and without
current MDE.
*Indicates significant differences p , 0.05.
MDE, major depressive episode.
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independently of MDE. The prevalence of 15.9% for anxiety
disorders may be considered relatively low; however, it is in
accordance with the reported prevalence rates of anxiety
disorders (current and lifetime) among FMS patients
ranging from 11% to 65%.5,12,53 Sixty-six percent of our
patients were using antidepressants, 23.1% were using
antipsychotics and 8.6% were using benzodiazepines, which
could have been enough to treat some cases of anxiety
disorder, but not depressive ones, and possibly, at least in
part, explain the relatively low prevalence of anxiety
disorders in our sample.
Two studies35,36 have investigated the association
between TCI and depression comorbid with other medical
conditions (in one study, MDD comorbid with heart disease;
in the other, MDD comorbid with Parkinson’s disease). In
both studies, the depression was only associated with HA.
Together with our findings, these data suggest that
depression comorbid with medical conditions has some
similarities when compared with primary depression. None
of these studies reported a difference in ST comparing
patients and control subjects. These results suggest that
several forms of depression comorbid with chronic pain
may be associated with normal ST levels.
Our findings of HA dysfunction in depression associated
with FMS does not preclude the possibility that non-
depressed FMS may also be associated with some degree
of HA dysfunction, as has been proposed by some authors.
Indeed, HA may be an essential trait in the perception of
pain. Pud et al. (2006)54 studied pain perception in healthy
volunteers and evaluated temperament traits with the
Cloninger’s tridimensional personality theory. Their results
showed that HA correlated with pain responsiveness, and a
higher HA was likely to predict a heightened pain response.
These data support the view that treating depression, and
consequently reducing HA, may be relevant to regularize
pain perceptions and achieve pain control in these patients.
Some limitations of our study should be considered.
Regarding the secondary hypotheses, while investigating
the association of MDE with the various dimensions of the
TCI, we performed multiple comparisons, increasing the
probability of a type I error. We evaluated only current
MDE and were not able to appraise a possible influence of
previous episodes of MDD on TCI dimensions. Our sample
comprised patients in a tertiary hospital; consequently,
generalization of our results for less severely affected
patients should be considered with prudence. We per-
formed a cross-sectional evaluation, and it is difficult to
determinate to what extent the evaluation of HA is biased
by a depressive state. Studies have demonstrated that HA
scores are higher during an episode of major depression
compared with the periods before and after remission of the
episode with successful treatment with antidepressants.26,55
However, patients with a diagnosis of MDD even before the
first episode or in a remission state after an episode have
higher HA scores than the general population. A recent
study treating depression in FMS patients revealed that HA
was state and trait dependent on depression.41 We
compared the association between HA and MDE found in
our FMS patients with literature data about the association
of TCI with primary depression. The inclusion of a control
group without fibromyalgia would offer more accurate
information for this comparison. However, it should be
remembered that our objective was to investigate the
association of TCI and depression in FMS patients and not
a comparison of TCI between FMS patients and those
without FMS. The TCI requires a minimum of schooling; for
Brazilian samples, it has been reported that at least 4 years
of instruction are necessary.49 Because of this, in our
screening phase, 73 patients were excluded for inability to
comprehend the TCI instructions. Consequently, it is
difficult to infer whether the results of our study are
applicable for patients with poor schooling.
In conclusion, although several studies have evaluated
the coexistence of FMS and psychiatric disorders, data about
the specific characteristics of comorbid depression are
sparse. Our data support the view that patients with FMS
are heterogeneous, particularly regarding the existence of a
subgroup with comorbid depression. The association of
depression with increased levels of HA and also with
decreased levels of SD and C, found in our sample, suggests
that depression in FMS patients may deserve special focus
considering the clinical and psychophysiological implica-
tions of TCI dimensions. New research should consider the
relevance of depression and its association with TCI
dimensions with respect to fibromyalgia treatment and
prognosis.
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